Bigworld, the people I consult, however irregularly, have given me a feeling of optomism in the very short term. No insider stuff here, but I have been told that the China "relationship" may offer the company a synDNA order that will get things on a faster track than waiting for approvals here. I have been told that CYGX can produce 10 grams of synDNA per day now (I can't substantiate this view myself) which could provide a decent amount of revenue for the company even at a drastically reduced rate from the usual DNA production. There exists the possibilty of delivering enough synDNA with current production facilities to help finance the company's expansion with a receivable (from RPC?), which is called factoring in the financing community, to build the company's new facility without selling more stock. Let's take heart! And I hope I'm not passing along BS. Please do your own DD. Take care.
